Jingrui Jiang - Concepedia

Author

Jingrui Jiang

Dana-Farber Cancer Institute

Also Known As

Jianping Jiang, Jingrui Jiang

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Novartis (Switzerland)Vlaams Instituut voor Biotechnologie

About

Jingrui Jiang is an author at Dana-Farber Cancer Institute specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	487
2	Cell Biology	6	6	292
3	Natural Sciences	2	2	126
4	Engineering	1	1	195
5	Immunology	1	1	17

Jingrui Jiang

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Identification of Driver and Passenger Mutations of FLT3 by High-Throughput DNA Sequence Analysis and Functional Assessment of Candidate Alleles Stefan Fröhling, Claudia Scholl, Ross L. Levine, Cancer Cell Genetic AnalysisFunctional AssessmentAllelic VariantEngineeringGenetic Disorder	2007	195
Epidermal Growth Factor–Independent Transformation of Ba/F3 Cells with Cancer-Derived Epidermal Growth Factor Receptor Mutants Induces Gefitinib-Sensitive Cell Cycle Progression Jingrui Jiang, Heidi Greulich, Pasi A. Jänne, Cancer Research	2005	184
Beneficial effects of combining nilotinib and imatinib in preclinical models of BCR-ABL+ leukemias Ellen Weisberg, Laurie Catley, Renee D. Wright, Blood	2006	106
Effects of PKC412, Nilotinib, and Imatinib Against GIST-Associated PDGFRA Mutants With Differential Imatinib Sensitivity Ellen Weisberg, Renee D. Wright, Jingrui Jiang, Gastroenterology Differential Imatinib SensitivityMedicineReceptor Tyrosine KinaseTumor SuppressorRadiation Oncology	2006	93
A Robust Error Model for iTRAQ Quantification Reveals Divergent Signaling between Oncogenic FLT3 Mutants in Acute Myeloid Leukemia Yi Zhang, Manor Askenazi, Jingrui Jiang, Molecular & Cellular Proteomics Robust Error ModelMixed-phenotype Acute LeukemiaGeneticsMolecular BiologyTumor Biology	2009	91
Allele-dependent variation in the relative cellular potency of distinct EGFR inhibitors Yuki Yuza, Karen A. Glatt, Jingrui Jiang, Cancer Biology & Therapy	2007	85
Potentiation of antileukemic therapies by the dual PI3K/PDK-1 inhibitor, BAG956: effects on BCR-ABL– and mutant FLT3-expressing cells Ellen Weisberg, Lolita Banerji, Renee D. Wright, Blood	2008	85
Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML Jingrui Jiang, J. Guillermo Paez, Jeffrey C. Lee, Blood	2004	83
Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells Ellen Weisberg, Andrew L. Kung, Renee D. Wright, Molecular Cancer Therapeutics	2007	77
Expression of a plant gene with sequence similarity to animal TGF‐β receptor interacting protein is regulated by brassinosteroids and required for normal plant development Jingrui Jiang, Steven D. Clouse The Plant Journal	2001	75

Page 1